Intellectual Property Protection and High Quality Development of Radix Glycyrrhizae for Treatment of COVID-19

Yuanpeng Sun, Yanling Sun, Zheng Cheng, Yusi Liu and Zhe Wu

Asian Agricultural Research, 2021, vol. 12, issue 05

Abstract: Radix Glycyrrhizae is the dominant native medicinal material variety in the north and northwestern medicinal materials producing areas. It is a main Chinese medicine of effective TCM drugs and formulas for the treatment of new coronavirus disease (COVID-19). This paper introduces the medicinal value of Radix Glycyrrhizae, involving the labeling, cultural heritage, and creative intellectual property rights of the Chinese medicinal materials, analyzes the poverty-stricken areas that are ecologically suitable for Radix Glycyrrhizae cultivation, and the superior counties and production bases of the Chinese medicinal materials. Besides, mainly from the aspects of perfect intellectual property rights, the establishment of authentic medicinal material production bases, and the construction of quality control systems, etc., it discusses the rural revitalization strategy and the development strategy of traditional Chinese medicine (TCM), agricultural intellectual property protection and high-quality development strategy of Radix Glycyrrhizae.

Keywords: Agribusiness (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ageconsearch.umn.edu/record/309091/files/I ... %20of%20COVID-19.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ags:asagre:309091

DOI: 10.22004/ag.econ.309091

Access Statistics for this article

More articles in Asian Agricultural Research from USA-China Science and Culture Media Corporation
Bibliographic data for series maintained by AgEcon Search ().